- Investing Ideas
- /
- Global Biotech Breakthroughs
Global Biotech Breakthroughs
Results
77
77 companies
Beijing Wantai Biological Pharmacy Enterprise
Market Cap: CN¥82.2b
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392
CN¥65.00
7D
-1.3%
1Y
1.1%
Nanjing Vazyme Biotech
Market Cap: CN¥9.6b
Offers technology solutions for life science, biomedicine, and in vitro diagnostics.
688105
CN¥24.46
7D
1.7%
1Y
4.7%
Everest Medicines
Market Cap: HK$19.0b
A biopharmaceutical company, engages in discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
1952
HK$58.45
7D
8.4%
1Y
154.1%
BioRestorative Therapies
Market Cap: US$13.9m
Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.
BRTX
US$1.80
7D
-1.6%
1Y
34.3%
Chimerix
Market Cap: US$799.2m
A biopharmaceutical company, develops medicines to improve and extend the lives of patients facing deadly diseases.
CMRX
US$8.53
7D
0.4%
1Y
720.2%
Active Biotech
Market Cap: SEK 94.7m
A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.
ACTI
SEK 0.077
7D
-15.9%
1Y
-87.1%
Unicycive Therapeutics
Market Cap: US$56.9m
A biotechnology company, develops treatments for various medical conditions in the United States.
UNCY
US$0.59
7D
-5.8%
1Y
-59.6%
ESSA Pharma
Market Cap: US$70.1m
A clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer.
EPIX
US$1.58
7D
2.6%
1Y
-80.6%
BeiGene
Market Cap: US$29.5b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$264.32
7D
0.7%
1Y
76.7%
Egetis Therapeutics
Market Cap: SEK 1.5b
A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.
EGTX
SEK 4.31
7D
18.1%
1Y
-39.0%
Anavex Life Sciences
Market Cap: US$728.1m
A clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases in the United States.
AVXL
US$8.30
7D
-13.0%
1Y
85.3%
Rhythm Pharmaceuticals
Market Cap: US$3.3b
A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.
RYTM
US$49.82
7D
-6.9%
1Y
24.2%
Aroa Biosurgery
Market Cap: AU$151.8m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.41
7D
-5.7%
1Y
-27.2%
BioInvent International
Market Cap: SEK 1.8b
A clinical-stage company, discovers, researches, and develops novel immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.
BINV
SEK 28.00
7D
-3.6%
1Y
53.2%
Vertex Pharmaceuticals
Market Cap: US$124.2b
A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).
VRTX
US$484.01
7D
-3.7%
1Y
19.8%
Ardelyx
Market Cap: US$1.2b
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$4.74
7D
-7.8%
1Y
-33.8%
CanSino Biologics
Market Cap: HK$11.9b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$33.65
7D
-1.9%
1Y
97.0%
Rocket Pharmaceuticals
Market Cap: US$671.8m
Operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the United States.
RCKT
US$5.56
7D
-29.4%
1Y
-77.7%
Mendus
Market Cap: SEK 280.0m
A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.
IMMU
SEK 5.56
7D
-7.3%
1Y
-42.1%
Mirum Pharmaceuticals
Market Cap: US$2.2b
A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.
MIRM
US$43.23
7D
-6.2%
1Y
70.7%
Day One Biopharmaceuticals
Market Cap: US$807.8m
A commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States.
DAWN
US$7.71
7D
-5.9%
1Y
-45.7%
Captor Therapeutics Spolka Akcyjna
Market Cap: zł179.5m
A biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.
CTX
zł38.50
7D
3.8%
1Y
-43.4%
Japan Tissue Engineering
Market Cap: JP¥17.6b
Engages in the regenerative medicine business in Japan.
7774
JP¥419.00
7D
-10.7%
1Y
-42.2%
Sierra Oncology
Market Cap: US$1.3b
Sierra Oncology, Inc., a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs.
SRRA
US$54.99
7D
0.06%
1Y
179.4%
Scholar Rock Holding
Market Cap: US$3.1b
A biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.
SRRK
US$30.70
7D
-8.0%
1Y
113.2%
GeoVax Labs
Market Cap: US$16.3m
A clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform.
GOVX
US$1.10
7D
-13.4%
1Y
-45.3%
Arcturus Therapeutics Holdings
Market Cap: US$276.6m
Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.
ARCT
US$9.49
7D
-21.0%
1Y
-69.0%
Zai Lab
Market Cap: US$4.0b
Develops and commercializes products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.
ZLAB
US$36.69
7D
1.4%
1Y
137.5%
Apellis Pharmaceuticals
Market Cap: US$2.9b
A commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs.
APLS
US$22.52
7D
-7.2%
1Y
-59.8%
Geron
Market Cap: US$1.0b
A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.
GERN
US$1.47
7D
-10.9%
1Y
-54.2%
PYC Therapeutics
Market Cap: AU$633.6m
A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.
PYC
AU$1.09
7D
-12.8%
1Y
17.2%
2seventy bio
Market Cap: US$259.6m
A cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States.
TSVT
US$4.97
7D
0.4%
1Y
-0.8%
Valneva
Market Cap: €515.1m
A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.
VLA
€3.17
7D
-5.4%
1Y
-16.0%
Modus Therapeutics Holding
Market Cap: SEK 46.7m
A biotechnology company, develops a treatment for sepsis and septic shock in Sweden.
MODTX
SEK 1.30
7D
1.6%
1Y
16.1%
Takara Bio
Market Cap: JP¥95.9b
Engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally.
4974
JP¥779.00
7D
-7.8%
1Y
-18.9%
Seegene
Market Cap: ₩1.1t
Manufactures and sells molecular diagnostics products worldwide.
A096530
₩22,700.00
7D
-5.2%
1Y
-3.4%